about
Molecular profiling of patient-derived breast cancer xenograftsRespective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinomaHuman papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients.Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification.Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational studyLong-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas.Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.Concurrent use of aromatase inhibitors and hypofractionated radiation therapy.Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study.Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort.First description of a sporadic breast cancer in a woman with BRCA1 germline mutation.Chromatin Regulators as a Guide for Cancer Treatment ChoiceTumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment.Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas.
P50
Q21195204-487EFAC4-FD95-4AD5-95DD-6F82387FCE8DQ28730529-6F0CA5DC-AC81-4206-BE9D-68BAC520233EQ34399129-70857AC4-E719-4AE6-A2A6-DA9F09A29743Q34443092-7A6787C2-6037-4E4F-9ECB-FCBD80D1E728Q34493571-91562934-6B86-4E56-B048-BF7D9FEC20AAQ34633934-DD0ED6C0-FF12-4D15-9326-8D7BEC206323Q35021646-FCA8A5D7-6C89-49B9-81D7-7636AA7C90BEQ35873283-7FDCFA4D-7852-4AAE-9A7D-F884E5F01519Q36166552-4C3B9A7A-AEAC-4286-9288-B64E130B81E4Q36393209-008D47CF-08D8-449A-90C0-8C4F45A284C9Q36473001-D4610A3A-F28E-4B03-8E69-DE50D53D7547Q36546414-C583BDC2-78A4-43D5-8D40-7EFB47E0464BQ37075234-E89E1362-0680-402D-9697-D7A98A938D87Q37360208-35E9AAF4-A3F1-4F6F-9380-D3E1B1A5955EQ37669469-729A55DF-14EC-4C5D-9126-E0B2680AF868Q37687387-A74E525A-5F1E-4426-A427-C235A518F9E4
P50
description
onderzoeker
@nl
name
Paul Cottu
@ast
Paul Cottu
@en
Paul Cottu
@es
Paul Cottu
@sl
type
label
Paul Cottu
@ast
Paul Cottu
@en
Paul Cottu
@es
Paul Cottu
@sl
prefLabel
Paul Cottu
@ast
Paul Cottu
@en
Paul Cottu
@es
Paul Cottu
@sl